Clinical Trials Logo

Obstetric Labor, Premature clinical trials

View clinical trials related to Obstetric Labor, Premature.

Filter by:

NCT ID: NCT05084326 Completed - Clinical trials for Labor Onset and Length Abnormalities

Engagement of Fetal Head as a Predictor of a Successful Vaginal Delivery in Primigravidas Presented in Early Labor.

Start date: November 3, 2020
Phase:
Study type: Observational

In primigravida, Delayed engagement of fetal head has been theorized that it is more likely in women with a possible cephalo-pelvic disproportion, so far they are associated with higher risk of cervical dystocia, which led to increased rate of caesarean section.

NCT ID: NCT04748562 Completed - Clinical trials for Twin Pregnancy With Antenatal Problem

Vaginal Progesterone 400mg v.s 200mg for Prevention of Preterm Labor in Twin Pregnancies

Start date: January 1, 2020
Phase: Phase 4
Study type: Interventional

It is already known that the risk of preterm labor in twin pregnancy before 37 week is 8-9 fold higher compared to singletons, and progesterone supplementation can decrease the incidence of preterm labor in singleton pregnancy. There were studies that used 200mg vaginal progesterone with no effect on the result So this study aims To examine the effect of prophylactic vaginal progesterone 400mg v.s 200mg for prevention of preterm birth in twin pregnancies

NCT ID: NCT04605172 Completed - Premature Birth Clinical Trials

Lockdown Impact on Spontaneous Premature Birth in a Level III NICU

CONFINéo
Start date: November 2, 2020
Phase:
Study type: Observational

Preterm labor (PL) is the leading cause of hospitalization during pregnancy and premature birth the leading cause of fetal morbidity and mortality in France. PL is defined by regular and painful uterine contractions associated with a change in the cervix, between 22 and 36 weeks of gestation. It has been shown that the risk of spontaneous prematurity increases particularly in case of working over 40 hours per week, hard physically conditions, or prolonged daily transport time. Rest is one of the most efficient measure to prevent PL and should be proposed to all pregnant women, and combined with other therapies such as tocolysis or cerclage when needed. The very particular period of lockdown during the COVID-19 pandemic had pregnant women to drastically reduce their activity. They suspended their work and stayed home for various reasons such as pregnancy in progress, children at home, and also collective reasons such as teleworking or workplace closure. During the lockdown period from March 17th to May 11th 2020, fewer preterm labor and less spontaneous prematurity have been suspected by the neonatology and obstetrics teams throughout the Lorraine region. Our study aims to objectively confirm this observation. In this investigation we aim to find a relationship between lockdown, PL and spontaneous prematurity which would need to re-evaluate public health recommendations for pregnant women outside the lockdown.

NCT ID: NCT04599868 Completed - Clinical trials for Placenta Previa Bleeding

High Versus Low Dose of Magnesium Sulfate as Initial Tocolytic Agent for Preterm Labour in Symptomatic Placenta Previa.

Start date: December 1, 2020
Phase: Phase 2
Study type: Interventional

To assess the efficacy and safety of alternative magnesium sulfate regimens when used as single agent tocolytic therapy for prevention of preterm labour in patients with symptomatic placenta previa and subsequent changes in the cervical length .

NCT ID: NCT04584814 Completed - Preterm Labor Clinical Trials

Analyze Changes in Respiratory Rate When Using the Scare Respirator

RESPSUS
Start date: March 1, 2020
Phase: N/A
Study type: Interventional

Pilot study of 10 preterm, who are going to be randomly placed to 3 phases : 2 hour of basal observation of respiratory rate, heart rate, saturation, NIPS and aEEG recording, 2 hours with a 20cycles/minute with "scare ventilator", and 2 hours of 40 cycles/minute with "scare ventilator"

NCT ID: NCT04568551 Completed - Anxiety State Clinical Trials

COVID-19-associated Anxiety of Pregnant Women for Anomalies, Stillbirth and Preterm Labor

CAASP
Start date: October 30, 2020
Phase:
Study type: Observational

Capture of anxiety for anomalies, stillbirth and preterm Labor of pregnant women during COVID-19 pandemia

NCT ID: NCT04554745 Completed - Preterm Labor Clinical Trials

The Cervical Length and Thickness of Cesarean Section Scar With Preterm Labor

Start date: February 1, 2021
Phase: N/A
Study type: Interventional

Although the Cesarean section is one of the most common obstetric operations around the world, the World Health Organization recognizes that where cesarean rates are higher than 10%, there is no increase in beneficial maternal and newborn outcomes. some researchers noted that in countries where cesarean rates are above 15%, populations experience higher maternal, infant, and neonatal mortality rates. infants born by cesarean delivery are more likely to require neonatal intensive care unit and have greater respiratory complications, and higher odds for childhood asthma, and obesity. Preterm is defined as babies born alive before completing 37 weeks of pregnancy. Preventing Preterm birth is a global priority due to increased risk for neonatal morbidity and mortality.

NCT ID: NCT04494529 Completed - Preterm Birth Clinical Trials

Single Dose Antenatal Corticosteroids (SNACS) for Women at Risk of Preterm Birth

SNACS Pilot
Start date: March 1, 2021
Phase: Phase 3
Study type: Interventional

Antenatal corticosteroids (ACS) reduce the risks of neonatal death and morbidities, such as respiratory distress syndrome, in preterm infants. Standard of care for women at risk of preterm birth includes 2 doses of 12 mg betamethasone (for a total of 24 mg) to accelerate fetal lung maturity. We plan to conduct a pilot clinical trial to determine the feasibility of a trial comparing half the usual dose (total 12 mg) of betamethasone to the standard double dose (total 24 mg) of betamethasone. The results of this pilot will be combined with the full-scale RCT (NCT05114096) for which we have received funding from the Canadian Institutes of Health Research (CIHR).

NCT ID: NCT04451928 Completed - Preterm Birth Clinical Trials

Prediction of Preterm Delivery by Serum Ischemia Modified Albumin, Biglycan and Decorin Levels in Women With Threatened Preterm Labour

Start date: December 1, 2019
Phase:
Study type: Observational [Patient Registry]

In this study, the levels of ischemia modified albumin, biglycan and decorin in the serums of pregnant women hospitalized for preterm labor will be examined. Their serum levels will be compared between women having preterm and term delivery. Their accuracy will be asessed in predicting preterm birth.

NCT ID: NCT04390659 Completed - Clinical trials for Obstetric Labor, Premature

Myomectomy During Cesarean Section Is This Aright Decision

Start date: August 15, 2014
Phase:
Study type: Observational

myomectomy was done during cesarean section